Drug application
MEPROSPAN (MEPROBAMATE)
Drugs@FDA NDA 011284 · MEDPOINTE PHARM HLC
Key facts
| Drug name | MEPROSPAN |
|---|---|
| Active ingredients | MEPROBAMATE |
| Application type | NDA |
| Application number | 011284 |
| Company | MEDPOINTE PHARM HLC |
| Dosage forms | CAPSULE, EXTENDED RELEASE, ORAL |
| Strength | 200MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.